A detailed history of Comerica Bank transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 10,944 shares of AXSM stock, worth $992,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,944
Previous 7,979 37.16%
Holding current value
$992,949
Previous $642,000 53.12%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $234,027 - $284,165
2,965 Added 37.16%
10,944 $983,000
Q2 2024

Aug 15, 2024

SELL
$65.72 - $80.5 $71,503 - $87,584
-1,088 Reduced 12.0%
7,979 $642,000
Q1 2024

May 15, 2024

BUY
$69.39 - $97.64 $621,109 - $873,975
8,951 Added 7716.38%
9,067 $723,000
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $3,674 - $5,351
64 Added 123.08%
116 $9,000
Q3 2023

Nov 21, 2023

BUY
$69.25 - $82.21 $3,601 - $4,274
52 New
52 $3,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.